Skip to main content
. 2021 Jan 26;11:2231. doi: 10.1038/s41598-021-81819-y

Figure 1.

Figure 1

Low-dose recombinant AMH (LR-AMH) promotes cell viability in COV434-AMHRII, SKOV3-AMHRII, OVCAR8 and KGN cells. (a) Cell viability (MTS assay) and (b) AKT phosphorylation (western blotting) after incubation with 0.8 to 25 nM LR-AMH for 3 days. (c) AMH expression at 48 h after transfection of siRNAs against AMH, and (d) Effect of siRNA-mediated AMH silencing on cell viability at day 3 post-transfection. Figure shows a representative experiment out of 2 to 4 experiments performed depending on the cell line (mean ± SEM of 3 replicate wells) *p < 0.05; ***p < 0.001. For western blot figure preparation, all proteins were analyzed on the same gel and membrane. After blotting, the lines corresponding to the different proteins were cut and may have been exposed for different lengths of time because the objective was not to compare the different proteins with each other, but to see the effect of AMH (b) or of siRNA (c) on the expression of each protein.